Sana Biotechnology's stock jumped after the company discussed early Phase 1 trial results from its SC291 CAR T-cell therapy
https://www.marketwatch.com/story/sana-biotechnology-stock-jumps-after-early-data-on-car-t-cell-therapy-36f97882
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.